Kelsen D - Search Results

1

A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma.

Lowery M, Shah MA, Smyth E, Epstein A, Segal A, Rosengarten O, Isacson R, Drukker L, Keinan A, Rachkiman M, Reissman P, Gabizon A, Kelsen D, O'Reilly EM. Lowery M, et al. Among authors: kelsen d. J Gastrointest Cancer. 2011 Sep;42(3):160-4. doi: 10.1007/s12029-010-9197-1. J Gastrointest Cancer. 2011. PMID: 20711688

2

A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.

Kelsen D, Martin DS, Colofiore J, Sawyer R, Coit D. Kelsen D, et al. Cancer. 1992 Oct 1;70(7):1988-92. doi: 10.1002/1097-0142(19921001)70:7<1988::aid-cncr2820700730>3.0.co;2-k. Cancer. 1992. PMID: 1381991 Clinical Trial.

3

Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma.

Casper ES, Schwartz GK, Kelsen DP. Casper ES, et al. Among authors: kelsen dp. Invest New Drugs. 1992 Aug;10(3):205-9. doi: 10.1007/BF00877247. Invest New Drugs. 1992. PMID: 1385354 Clinical Trial.

4

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.

Casper ES, Schwartz GK, Johnson B, Kelsen DP. Casper ES, et al. Among authors: kelsen dp. Invest New Drugs. 1992 Nov;10(4):313-6. doi: 10.1007/BF00944187. Invest New Drugs. 1992. PMID: 1487406 Clinical Trial.

5

Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma.

Markman M, Kelsen D. Markman M, et al. Among authors: kelsen d. J Cancer Res Clin Oncol. 1992;118(7):547-50. doi: 10.1007/BF01225271. J Cancer Res Clin Oncol. 1992. PMID: 1624547 Clinical Trial.

6

A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.

Bajorin D, Kelsen DP. Bajorin D, et al. Among authors: kelsen dp. Cancer Invest. 1990;8(2):135-41. doi: 10.3109/07357909009017558. Cancer Invest. 1990. PMID: 1698110

7

A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.

Kelsen D, Hudis C, Niedzwiecki D, Dougherty J, Casper E, Botet J, Vinciguerra V, Rosenbluth R. Kelsen D, et al. Cancer. 1991 Sep 1;68(5):965-9. doi: 10.1002/1097-0142(19910901)68:5<965::aid-cncr2820680509>3.0.co;2-2. Cancer. 1991. PMID: 1833042 Clinical Trial.

8

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.

Crown J, Casper ES, Botet J, Murray P, Kelsen DP. Crown J, et al. Among authors: kelsen dp. J Clin Oncol. 1991 Sep;9(9):1682-6. doi: 10.1200/JCO.1991.9.9.1682. J Clin Oncol. 1991. PMID: 1875224

9

A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus.

Lovett D, Kelsen D, Eisenberger M, Houston C. Lovett D, et al. Among authors: kelsen d. Cancer. 1991 Jan 15;67(2):354-6. doi: 10.1002/1097-0142(19910115)67:2<354::aid-cncr2820670206>3.0.co;2-l. Cancer. 1991. PMID: 1985729 Clinical Trial.

10

Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.

Minsky BD, Kemeny N, Cohen AM, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kelsen dp. Cancer. 1991 Jun 1;67(11):2859-66. doi: 10.1002/1097-0142(19910601)67:11<2859::aid-cncr2820671126>3.0.co;2-w. Cancer. 1991. PMID: 2025851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters